BWAM
Boyd Watterson Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9K | Buy |
467
+222
| +91% | +$8.53K | 0.01% | 257 |
|
|
2025
Q1 | $9.49K | Hold |
245
| – | – | ﹤0.01% | 299 |
|
|
2024
Q4 | $8.29K | Hold |
245
| – | – | ﹤0.01% | 315 |
|
|
2024
Q3 | $10K | Sell |
245
-6
| -2% | -$245 | ﹤0.01% | 309 |
|
|
2024
Q2 | $9.66K | Hold |
251
| – | – | ﹤0.01% | 311 |
|
|
2024
Q1 | $10.8K | Hold |
251
| – | – | ﹤0.01% | 304 |
|
|
2023
Q4 | $9.3K | Hold |
251
| – | – | ﹤0.01% | 309 |
|
|
2023
Q3 | $9.1K | Hold |
251
| – | – | ﹤0.01% | 305 |
|
|
2023
Q2 | $8.95K | Hold |
251
| – | – | ﹤0.01% | 310 |
|
|
2023
Q1 | $8.93K | Hold |
251
| – | – | ﹤0.01% | 313 |
|
|
2022
Q4 | $8.82K | Buy |
+251
| New | +$8.82K | ﹤0.01% | 316 |
|
|
2016
Q4 | – | Sell |
-8,065
| Closed | -$348K | – | 149 |
|
|
2016
Q3 | $348K | Sell |
8,065
-2,222
| -22% | -$95.9K | 0.17% | 123 |
|
|
2016
Q2 | $446K | Sell |
10,287
-79
| -0.8% | -$3.43K | 0.21% | 120 |
|
|
2016
Q1 | $420K | Buy |
10,366
+2,163
| +26% | +$87.6K | 0.2% | 121 |
|
|
2015
Q4 | $331K | Sell |
8,203
-3,560
| -30% | -$144K | 0.16% | 124 |
|
|
2015
Q3 | $452K | Buy |
11,763
+1,178
| +11% | +$45.3K | 0.19% | 119 |
|
|
2015
Q2 | $441K | Buy |
10,585
+40
| +0.4% | +$1.67K | 0.17% | 131 |
|
|
2015
Q1 | $487K | Buy |
10,545
+2,599
| +33% | +$120K | 0.2% | 122 |
|
|
2014
Q4 | $340K | Sell |
7,946
-1,155
| -13% | -$49.4K | 0.15% | 134 |
|
|
2014
Q3 | $418K | Buy |
9,101
+339
| +4% | +$15.6K | 0.18% | 134 |
|
|
2014
Q2 | $469K | Sell |
8,762
-31
| -0.4% | -$1.66K | 0.2% | 126 |
|
|
2014
Q1 | $470K | Buy |
8,793
+907
| +12% | +$48.5K | 0.22% | 121 |
|
|
2013
Q4 | $421K | Sell |
7,886
-2,243
| -22% | -$120K | 0.2% | 128 |
|
|
2013
Q3 | $508K | Buy |
10,129
+850
| +9% | +$42.6K | 0.24% | 99 |
|
|
2013
Q2 | $464K | Buy |
+9,279
| New | +$464K | 0.24% | 99 |
|